Trial Profile
Effect of Pioglitazone on stroke risk and outcomes in patients with Type 2 Diabetes Mellitus :a retrospective, observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2019
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 18 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association